Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05493501
Title Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors EQRx International, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
Memorial Cancer Institute Hollywood Florida 33021 United States Details
Memorial Cancer Institute Pembroke Pines Florida 33028 United States Details
QCCA - Mission Blood & Cancer Des Moines Iowa 50314 United States Details
Summit Health Florham Park New Jersey 07932 United States Details
SCRI - Tennessee Oncology PLLC- Chattanooga Chattanooga Tennessee 37404 United States Details
SCRI - Tennessee Oncology- Nashville Nashville Tennessee 37203 United States Details
Northwest Medical Specialties, PLLC Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field